top of page

Q1 2025 warning letter roundup with Asa Waldstein

Asa Waldstein

Q1 2025 warning letter roundup with Asa Waldstein

Guest Article

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

At a Glance

  • Six animal product companies received FDA warning letters for making serious disease claims.

  • A warning letter reinforces the importance of following purity, strength and composition specifications.

  • There was only one CBD-related warning letter this quarter, and it was a doozy.

AHPA-member-logo.png
  • LinkedIn
  • YouTube
  • Facebook

American Herbal Products Association (AHPA) Member

©2024 by Supplement Advisory Group LLC. All Rights Reserved

Disclaimer: The educational information provided on this website is for informational purposes only. Contact an attorney for specific legal advice.  Rule #1 in compliance is to ensure marketing is truthful and not misleading.

​

Privacy Policy. |. Terms of Use. |. Sitemap

bottom of page